A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients
Clinical trial NCT07151820 · COMPLETED
Trial details
- NCT number
- NCT07151820
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-08
- Primary completion
- 2024-10-22
- Enrollment
- 2546
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.